These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17426318)

  • 21. Endocannabinoids: synthesis and degradation.
    Di Marzo V
    Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity.
    Ge Q; Maury E; Rycken L; Gérard J; Noël L; Detry R; Navez B; Brichard SM
    Int J Obes (Lond); 2013 Jun; 37(6):874-80. PubMed ID: 22868830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion.
    Quartu M; Poddighe L; Melis T; Serra MP; Boi M; Lisai S; Carta G; Murru E; Muredda L; Collu M; Banni S
    Lipids Health Dis; 2017 Jan; 16(1):14. PubMed ID: 28103941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclolepis genistoides D. Don (palo azul) promotes differentiation of adipocytes and regulates adipokine expression.
    Sato H; Ishikawa M; Funaki A; Kimura Y; Yoshida H; Fukata H; Hasegawa H; Ueno K
    Nutr Res; 2013 Nov; 33(11):922-31. PubMed ID: 24176232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats.
    Batetta B; Griinari M; Carta G; Murru E; Ligresti A; Cordeddu L; Giordano E; Sanna F; Bisogno T; Uda S; Collu M; Bruheim I; Di Marzo V; Banni S
    J Nutr; 2009 Aug; 139(8):1495-501. PubMed ID: 19549757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.
    Wang H; Xie H; Sun X; Kingsley PJ; Marnett LJ; Cravatt BF; Dey SK
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):62-74. PubMed ID: 17259073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.
    Côté M; Matias I; Lemieux I; Petrosino S; Alméras N; Després JP; Di Marzo V
    Int J Obes (Lond); 2007 Apr; 31(4):692-9. PubMed ID: 17224929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral Endocannabinoids Associated With Energy Expenditure in Native Americans of Southwestern Heritage.
    Heinitz S; Basolo A; Piaggi P; Piomelli D; Jumpertz von Schwartzenberg R; Krakoff J
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1077-1087. PubMed ID: 29300902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocannabinoids in adipocytes during differentiation and their role in glucose uptake.
    Gasperi V; Fezza F; Pasquariello N; Bari M; Oddi S; Agrò AF; Maccarrone M
    Cell Mol Life Sci; 2007 Jan; 64(2):219-29. PubMed ID: 17187172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
    Després JP
    Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture.
    Martins CJ; Genelhu V; Pimentel MM; Celoria BM; Mangia RF; Aveta T; Silvestri C; Di Marzo V; Francischetti EA
    PLoS One; 2015; 10(11):e0142728. PubMed ID: 26561012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
    Vidal-Puig A; Jimenez-Liñan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE
    J Clin Invest; 1996 Jun; 97(11):2553-61. PubMed ID: 8647948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects.
    Engeli S; Lehmann AC; Kaminski J; Haas V; Janke J; Zoerner AA; Luft FC; Tsikas D; Jordan J
    Obesity (Silver Spring); 2014 May; 22(5):E70-6. PubMed ID: 24616451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocannabinoid system and pathophysiology of adipogenesis: current management of obesity.
    Iqbal O
    Per Med; 2007 Aug; 4(3):307-319. PubMed ID: 29788669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity.
    Quercioli A; Pataky Z; Vincenti G; Makoundou V; Di Marzo V; Montecucco F; Carballo S; Thomas A; Staub C; Steffens S; Seimbille Y; Golay A; Ratib O; Harsch E; Mach F; Schindler TH
    Eur Heart J; 2011 Jun; 32(11):1369-78. PubMed ID: 21303779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoids and non-endocannabinoid fatty acid amides in cirrhosis.
    Ying-Ying Y; Lin HC
    Liver Int; 2010 Jul; 30(6):780-1. PubMed ID: 20408944
    [No Abstract]   [Full Text] [Related]  

  • 37. Peripheral endocannabinoid system activity in patients treated with sibutramine.
    Engeli S; Heusser K; Janke J; Gorzelniak K; Bátkai S; Pacher P; Harvey-White J; Luft FC; Jordan J
    Obesity (Silver Spring); 2008 May; 16(5):1135-7. PubMed ID: 18356837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAAH and anandamide: is 2-AG really the odd one out?
    Di Marzo V; Maccarrone M
    Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human adipocytes from the subcutaneous superficial layer have greater adipogenic potential and lower PPAR-γ DNA methylation levels than deep layer adipocytes.
    Kosaka K; Kubota Y; Adachi N; Akita S; Sasahara Y; Kira T; Kuroda M; Mitsukawa N; Bujo H; Satoh K
    Am J Physiol Cell Physiol; 2016 Aug; 311(2):C322-9. PubMed ID: 27251439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.